No, the amount of time and effort required to Vaccinate the Population is a massive undertaking. Mab's will serve to bridge that gap by freeing up Hospitals to focus on critical Patients as well as what they need to treat on a normal basis. Even if you take Covid out of the equation HGEN is still advancing on many important combinations specifically thier Collaboration with Kite/Gilead in late stage trial for Lymphoma.
Covid has given the opportunity to further test and support efficacy in Lenzilumab and shown support for how quickly HGEN could react to an Emergency and possibly provide a solution to Hospital overcrowding.
Vaccines have never been a concern of mine in relation to my investment in Humanigen.
Not one bit. After the study showing antibodies don’t last, therapeutics are paramount. Anyway, vaccines won’t be ready for another year imo so we definitely need help saving lives until then (and beyond)
News 
Market Data 
Discover 
